Oncternal Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2020
Period Ending	Aug '25 Aug 12, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020	2017 - 2020
Market Capitalization	36	29	11	12	27	3	Upgrade
Market Cap Growth	178.79%	153.38%	-2.15%	-57.60%	723.47%	33.33%	Upgrade
Enterprise Value	30	28	9	11	25	3	Upgrade
Last Close Price	0.46	0.44	0.17	0.22	0.52	0.08	Upgrade
PB Ratio	6.56	69.67	8.04	-490.34	14.48	5.33	Upgrade
P/TBV Ratio	6.56	69.67	8.04	-	14.48	5.33	Upgrade
Quick Ratio	54.50	7.56	4.70	0.79	4.05	21.41	Upgrade
Current Ratio	54.84	7.90	4.77	0.84	4.08	21.65	Upgrade
Return on Equity (ROE)	-44.77%	-129.42%	-205.02%	-233.51%	-114.18%	-35.92%	Upgrade
Return on Assets (ROA)	-25.91%	-59.67%	-85.28%	-93.94%	-54.90%	-20.81%	Upgrade
Return on Capital (ROIC)	-28.81%	-81.61%	-125.19%	-138.09%	-68.82%	-21.54%	Upgrade
Earnings Yield	-4.02%	-4.11%	-12.53%	-18.78%	-5.24%	-8.21%	Upgrade
Buyback Yield / Dilution	-7.18%	-7.66%	-14.55%	-10.18%	-15.15%	-	Upgrade

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.